EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Isopropoxy Benzene Guanidine Ameliorates Streptococcus suis Infection In Vivo and In Vitro

Ning Han iD, Jie Li, Feifei Zhao, Yangyang Li, Jun Wang, Xiaolan Dai, Dongping Zeng, Wenguang Xiong, Zhenling Zeng

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24087354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ning Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricu…. Hauptthemen laut MEDLINE: Streptococcus suis, Streptococcal Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Streptococcus suis, an encapsulated zoonotic pathogen, has been reported to cause a variety of infectious diseases, such as meningitis and streptococcal-toxic-shock-like syndrome. Increasing antimicrobial resistance has triggered the need for new treatments. In the present study, we found that isopropoxy benzene guanidine (IBG) significantly attenuated the effects caused by S. suis infection, in vivo and in vitro, by killing S. suis and reducing S. suis pathogenicity. Further studies showed that IBG disrupted the integrity of S. suis cell membranes and increased the permeability of S. suis cell membranes, leading to an imbalance in proton motive force and the accumulation of intracellular ATP. Meanwhile, IBG antagonized the hemolysis activity of suilysin and decreased the expression of Sly gene. In vivo, IBG improved the viability of S. suis SS3-infected mice by reducing tissue bacterial load. In conclusion, IBG is a promising compound for the treatment of S. suis infections, given its antibacterial and anti-hemolysis activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus suisStreptococcal InfectionsAnimalsMiceBenzeneGuanidineGuanidinesHemolysin Proteins

Stichwörter der Autor:innen

Streptococcus suisanti-hemolysisantibacterialisopropoxy benzene guanidinesuilysin

Substanzen

BenzeneGuanidineGuanidinesHemolysin Proteins

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
  • National Laboratory of Safety Evaluation (Environmental Assessment) of Veterinary Drugs, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
  • National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.

ORCID-Profile: Ning Han

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Han, N., Li, J., Zhao, F., Li, Y., Wang, J., Dai, X., Zeng, D., Xiong, W., & Zeng, Z. (2023). Isopropoxy Benzene Guanidine Ameliorates Streptococcus suis Infection In Vivo and In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24087354

Vancouver

Han N, Li J, Zhao F, Li Y, Wang J, Dai X, et al. Isopropoxy Benzene Guanidine Ameliorates Streptococcus suis Infection In Vivo and In Vitro. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24087354

BibTeX
@article{Han2023,
  author = {Han, Ning and Li, Jie and Zhao, Feifei and Li, Yangyang and Wang, Jun and Dai, Xiaolan and Zeng, Dongping and Xiong, Wenguang and Zeng, Zhenling},
  title = {Isopropoxy Benzene Guanidine Ameliorates Streptococcus suis Infection In Vivo and In Vitro},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24087354}
}
Kostenlos starten →